Antiangiogenic-Like Properties of Fermented Extracts of Ayurvedic Medicinal Plants

Journal of Medicinal Food

Volumn 18, Issue 9, 2015, Pages 1065-1072

  Rabhi, Chérif ^a   Arcile, Guillaume ^b   Cariel, Léon ^a   Lenoir, Christine ^b   Bignon, JéRome ^b   Wdzieczak Bakala, Joanna ^b   Ouazzani, Jamal ^b  

^a Laboratoire Ethnodyne   (France)

^b CNRS   (France)

Author keywords

age related macular degeneration; angiogenesis; Bacopa monnieri; Beauveria bassiana; Emblica officinalis; fermentation; Withania somnifera

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOGENESIS INHIBITOR; ASPARTATE AMINOTRANSFERASE; AYURVEDIC DRUG; BACOPA MONNIERI EXTRACT; BIOLOGICAL MARKER; EMBLICA OFFICINALIS EXTRACT; ETHNODYNE VISIO; GALLIC ACID; GLUCOGALLIN; NUTRACEUTICAL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG; WITHANIA SOMNIFERA EXTRACT; WITHANOLIDE;

AGE RELATED MACULAR DEGENERATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AYURVEDA; BACOPA MONNIERI; BEAUVERIA BASSIANA; BIOLOGICAL ACTIVITY; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG ISOLATION; DRUG POTENCY; DRUG STRUCTURE; EMBLICA OFFICINALIS; EMBRYO; EXTRACTION; FEMALE; FERMENTATION; FERMENTED PRODUCT; FLUIDIZATION; FUNGAL STRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE STATIC EXTRACTION; IN VITRO STUDY; IN VIVO STUDY; LD50; LIVER INJURY; MALE; MASS SPECTROMETRY; NECROSIS; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; VASCULARIZATION; WITHANIA SOMNIFERA; ANIMAL; BACOPA; BEAUVERIA; DIETARY SUPPLEMENT; DRUG EFFECTS; ENZYMOLOGY; LIVER; MACULAR DEGENERATION; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PHYTOTHERAPY; WISTAR RAT; WITHANIA;

ANGIOGENESIS INHIBITORS; ANIMALS; BACOPA; BEAUVERIA; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DIETARY SUPPLEMENTS; FEMALE; FERMENTATION; LIVER; MACULAR DEGENERATION; MALE; NEOVASCULARIZATION, PATHOLOGIC; PHYLLANTHUS EMBLICA; PHYTOTHERAPY; PLANT EXTRACTS; RATS, WISTAR; WITHANIA;

EID: 84929473506     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2014.0128     Document Type: Article

References (38)

1. Shibuya M: Vascular endothelial growth factor-dependent and-independent regulation of angiogenesis. BMB Rep 2008;41: 278-286.
2. Kaufmann P, Mayhewb TM, Charnock-Jonesc DS: Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 2004;25:114-126.
3. Nicholas S, Greaves NS, Ashcroft KJ, Baguneid M, Bayat A: Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J Dermatol Sci 2013;72:206-217.
4. Ding X, Mrinali Patel M, Chan C-C: Molecular pathology of agerelated macular degeneration. Prog Retin Eye Res 2009;28:1-18.
5. Miller JW, Le Couter J, Strauss EC, Ferrara N: Vascular endothelial growth factor A in intraocular vascular disease. Ophthalmology 2013;120:106-114.
6. Wirostko B, Wong TY, Simo R: Vascular endothelial growth factor and diabetic complications. Prog Retin Eye Res 2009;27: 608-621.
7. Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R, Giacomelli R: Angiogenesis in rheumatoid arthritis: A disease specific process or a common response to chronic inflammation? Autoimmun Rev 2011;10:595-598.
8. Armstrong AW, Voyles SV, Armstrong EJ, Fuller EN, Rutledge JC: Angiogenesis and oxidative stress: Common mechanisms linking psoriasis with atherosclerosis. J Dermatol Sci 2011;63: 1-9.
9. Paulo M, Hoff PM, Machado KK: A role of angiogenesis in the pathogenesis of cancer. Cancer Treat Rev 2012;38:825-833.
10. Los M, Roodhart JML, Voest EE: Target practice: Lessons from phase III trials with bevacizumab and vatalanib in the treatment of advanced colorectal cancer. Oncologist 2007;12:443-450.
11. Taylor S, Folkman J: Protamine is an inhibitor of angiogenesis. Nature 1982;297:307-312.
12. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 1990;348:555-557.
13. Bracarda S, Eggermont A, Samuelsson J: Redefining the role of interferon in the treatment of malignant diseases. Eur J Cancer 2010;46:284-297.
14. Madhusudan S, Harris AL: Drug inhibition of angiogenesis. Curr Opin Pharmacol 2002;2:403-414.
15. Aggarwal BB, Ichikawa H, Garodia P: From traditional ayurvedic medicine to modern medicine: Identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets 2006;10:87-118.
16. Aggarwal BB, Prasad S, Reuters S: Identification of novel antiinflammatory agents from ayurvedic medicine for prevention of chronic diseases: ''reverse pharmacology'' and ''bedside to bench'' approach. Curr Drug Targets 2011;12:1595-1653.
17. Patwardhan B, Mashelkar RA: Traditional medicine-inspired approaches to drug discovery: Can Ayurveda show the way forward? Drug Discov Today 2009;14:804-811.
18. Sulaiman RS, Basavarajappa HD, Corson TW: Natural product inhibitors of ocular angiogenesis. Exp Eye Res 2014;129C:161-171. (http://dx.doi.org/10.1016/j.exer.2014.10.002).
19. Mathur R, Gupta SK, Singh N, Mathur S, Kochupillai V, Velpandian T: Evaluation of the effect of Withania somnifera root extracts on cell cycle and angiogenesis. J Ethnopharmacol 2006;105:336-341.
20. Winters M: Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev 2006;11:269-277.
21. De A, De A, Papasian C, Hentges S, Banerjee S, Haque I, Banerjee SK: Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors. PLoS One 2013;8:e72748.
22. Kumar A, Singh A, Dora J: Essentials perspectives for Emblica officinalis. Int J Pharm Chem Sci 2012;1:11-18.
23. Pase MP, Kean J, Sarris J, Neale C, Scholey AB, Stough C: The cognitive-enhancing effects of Bacopa monnieri: A systematic review of randomized, controlled human clinical trials. J Altern Complement Med 2012;18:647-652.
24. Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, Nathan PJ: The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology 2001;156:481-484.
25. Liu J-M, Lawrence F, Kovacevic M, Bignon J, Papadimitriou JE, Lallemand J-Y, Katsoris P, Potier P, Fromes Y, Wdzieczak-Bakala J: The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo. Blood 2003;101:3014-3020.
26. Ouazzani J, Cortial S, Sergent D, Lopes P: Method for solid/ liquid extraction of substances from a mass of dry material and device for carrying out said method. French Patent WO 2008/ 141943, November 13, 2008.
27. Leverrier A, Tran Huu Dau ME, Retailleau P, Awang K, Gueritte F, Litaudon M, Kingianin A: A new natural pentacyclic compound from Endiandra kingiana. Org Lett 2010;12:3638-3641.
28. Marti G, Eparvier V, Litaudon M, Grellier P, Gueritte F: A new xanthone from the bark extract of Rheedia acuminata and antiplasmodial activity of its major compounds. Molecules 2010;15: 7106-7114.
29. Ghosal S: Withania somnifera Composition. WO 01/03715 A.1. 2011.
30. Chaudhary A, Singh N, Dalvi M, Wele A: A progressive review of Sandhana kalpana (Biomedical fermentation): An advanced innovative dosage form of Ayurveda. Ayu 2011;32:408-417.
31. Banerjee S, Singh S, Ur Rahman L: Biotransformation studies using hairy root cultures-A review. Biotechnol Adv 2011;30: 461-468.
32. Joo SS, Won TJ, Nam SY, Kim YB, Lee YC, Park SY, Park HY, Hwang KW, Lee DI: Therapeutic advantages of medicinal herbs fermented with Lactobacillus plantarum, in topical application and its activities on atopic dermatitis. Phytother Res 2009;23: 913-919.
33. Manwar J, Mahadik K, Sathiyanarayanan L, Paradkar A, Patil S: Comparative antioxidant potential of Withania somnifera based herbal formulation prepared by traditional and non-traditional fermentation processes. Integr Med Res 2013;2:56-61.
34. Grogan GJ, Holland HL: The biocatalytic reactions of Beauveria spp. J Mol Catal B Enzym 2000;9:1-32.
35. Feng MG, Poprawski TJ, Khachatourians GG: Production, formulation and application of the entomopathogenic fungus Beauveria bassiana for insect control: Current status. Biocontrol Sci Tech 1994;4:3-34.
36. Quesada-Moraga E, Yousef M, Ortiz A: Beauveria bassiana (Ascomycota: Hypocreales) wound dressing for the control of Euzophera pinguis (Lepidoptera: Pyralidae). J Econ Entomol 2013;106:1602-1607.
37. Qiao LR, Xie D, Quan Liu Q, Zou J, Shen Z, Dai J: Microbial transformation of lovastatin by Beauveria bassiana. Acta Pharm Sin B 2012;2:300-305.
38. Zhan J, Gunatilaka AAL: Microbial metabolism of 1-aminoanthracene by Beauveria bassiana. Bioorg Med Chem 2008;16: 5085-5089.